Proton Beam Therapy for Thymic Carcinoma with Pericardial Involvement
Purpose: Thymic malignancies are the most common anterior mediastinal tumors. Advanced thymic carcinoma treatment relies on chemotherapy and definitive radiation therapy when possible. However, pericardial involvement is problematic for radiation therapy treatment planning owing to significant cardi...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-11-01
|
Series: | International Journal of Particle Therapy |
Subjects: | |
Online Access: | https://theijpt.org/doi/pdf/10.14338/IJPT-20-00023.1 |
_version_ | 1827160719514140672 |
---|---|
author | Pierre Loap, MSc Nathaniel Scher, MD Farid Goudjil, PhD Youlia Kirova, MD Nicolas Girard, MD Kim I. Cao, MD |
author_facet | Pierre Loap, MSc Nathaniel Scher, MD Farid Goudjil, PhD Youlia Kirova, MD Nicolas Girard, MD Kim I. Cao, MD |
author_sort | Pierre Loap, MSc |
collection | DOAJ |
description | Purpose: Thymic malignancies are the most common anterior mediastinal tumors. Advanced thymic carcinoma treatment relies on chemotherapy and definitive radiation therapy when possible. However, pericardial involvement is problematic for radiation therapy treatment planning owing to significant cardiac radiation exposure. We report the first case of definitive proton beam therapy (PBT) for an advanced thymic carcinoma with pericardial invasion.
Materials and Methods: We report the case of a 69-year-old patient treated with definitive radiation therapy for a stage IVB thymic carcinoma with pericardial invasion. Mean doses delivered to critical organs at risk were compared between deep inspiration breath-hold (DIBH) volumetric modulated arc therapy (VMAT) and DIBH-PBT.
Results: When compared to DIBH-VMAT, DIBH-PBT reduced the mean doses delivered to the heart by 3.72 Gy (19.0% dose reduction), to the right lung by 5.9 Gy (41.7% dose reduction), to the left lung by 3.63 Gy (19.0% dose reduction), and to the esophagus by 3.57 Gy (21.3% dose reduction). Despite an early mediastinal relapse after 3.0 months, our patient is still alive after a 14-month follow-up, without any radiation-induced cardiac adverse events and is undergoing pembrolizumab-based immunotherapy.
Conclusion: Proton beam therapy is an option for definitive irradiation of thymic malignancies invading the pericardium; in this situation, PBT reduces doses to the heart and may help to reduce cardiotoxicity when compared with photon techniques. |
first_indexed | 2024-04-24T08:36:10Z |
format | Article |
id | doaj.art-e064bce8b12e45a0b9a1a8667919e76d |
institution | Directory Open Access Journal |
issn | 2331-5180 |
language | English |
last_indexed | 2025-03-21T00:17:30Z |
publishDate | 2020-11-01 |
publisher | Elsevier |
record_format | Article |
series | International Journal of Particle Therapy |
spelling | doaj.art-e064bce8b12e45a0b9a1a8667919e76d2024-08-03T09:08:17ZengElsevierInternational Journal of Particle Therapy2331-51802020-11-0173657010.14338/IJPT-20-00023.12331-5180-7-3-65Proton Beam Therapy for Thymic Carcinoma with Pericardial InvolvementPierre Loap, MSc0Nathaniel Scher, MD1Farid Goudjil, PhD2Youlia Kirova, MD3Nicolas Girard, MD4Kim I. Cao, MD5Department of Radiation Oncology, Institut Curie, Paris, FranceDepartment of Radiation Oncology, Institut Curie, Paris, FranceDepartment of Radiation Oncology, Institut Curie, Paris, FranceDepartment of Radiation Oncology, Institut Curie, Paris, FranceDepartment of Radiation Oncology, Institut Curie, Paris, FranceDepartment of Radiation Oncology, Institut Curie, Paris, FrancePurpose: Thymic malignancies are the most common anterior mediastinal tumors. Advanced thymic carcinoma treatment relies on chemotherapy and definitive radiation therapy when possible. However, pericardial involvement is problematic for radiation therapy treatment planning owing to significant cardiac radiation exposure. We report the first case of definitive proton beam therapy (PBT) for an advanced thymic carcinoma with pericardial invasion. Materials and Methods: We report the case of a 69-year-old patient treated with definitive radiation therapy for a stage IVB thymic carcinoma with pericardial invasion. Mean doses delivered to critical organs at risk were compared between deep inspiration breath-hold (DIBH) volumetric modulated arc therapy (VMAT) and DIBH-PBT. Results: When compared to DIBH-VMAT, DIBH-PBT reduced the mean doses delivered to the heart by 3.72 Gy (19.0% dose reduction), to the right lung by 5.9 Gy (41.7% dose reduction), to the left lung by 3.63 Gy (19.0% dose reduction), and to the esophagus by 3.57 Gy (21.3% dose reduction). Despite an early mediastinal relapse after 3.0 months, our patient is still alive after a 14-month follow-up, without any radiation-induced cardiac adverse events and is undergoing pembrolizumab-based immunotherapy. Conclusion: Proton beam therapy is an option for definitive irradiation of thymic malignancies invading the pericardium; in this situation, PBT reduces doses to the heart and may help to reduce cardiotoxicity when compared with photon techniques.https://theijpt.org/doi/pdf/10.14338/IJPT-20-00023.1thymic carcinomacardiotoxicitydeep inspiration breath-holdproton beam therapy |
spellingShingle | Pierre Loap, MSc Nathaniel Scher, MD Farid Goudjil, PhD Youlia Kirova, MD Nicolas Girard, MD Kim I. Cao, MD Proton Beam Therapy for Thymic Carcinoma with Pericardial Involvement International Journal of Particle Therapy thymic carcinoma cardiotoxicity deep inspiration breath-hold proton beam therapy |
title | Proton Beam Therapy for Thymic Carcinoma with Pericardial Involvement |
title_full | Proton Beam Therapy for Thymic Carcinoma with Pericardial Involvement |
title_fullStr | Proton Beam Therapy for Thymic Carcinoma with Pericardial Involvement |
title_full_unstemmed | Proton Beam Therapy for Thymic Carcinoma with Pericardial Involvement |
title_short | Proton Beam Therapy for Thymic Carcinoma with Pericardial Involvement |
title_sort | proton beam therapy for thymic carcinoma with pericardial involvement |
topic | thymic carcinoma cardiotoxicity deep inspiration breath-hold proton beam therapy |
url | https://theijpt.org/doi/pdf/10.14338/IJPT-20-00023.1 |
work_keys_str_mv | AT pierreloapmsc protonbeamtherapyforthymiccarcinomawithpericardialinvolvement AT nathanielschermd protonbeamtherapyforthymiccarcinomawithpericardialinvolvement AT faridgoudjilphd protonbeamtherapyforthymiccarcinomawithpericardialinvolvement AT youliakirovamd protonbeamtherapyforthymiccarcinomawithpericardialinvolvement AT nicolasgirardmd protonbeamtherapyforthymiccarcinomawithpericardialinvolvement AT kimicaomd protonbeamtherapyforthymiccarcinomawithpericardialinvolvement |